APO Research

APO RESEARCH · REPORT

Bifunctional Epoxide Hydrolase 2

Selected research

Market Outlook & Growth Opportunities

Global Bifunctional Epoxide Hydrolase 2 Market Outlook and Growth Opportunities 2026

Market perspective

The global Bifunctional Epoxide Hydrolase 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bifunctional Epoxide Hydrolase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bifunctional Epoxide Hydrolase 2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bifunctional Epoxide Hydrolase 2 market include Sumitomo Dainippon Pharma Co., Ltd., GlaxoSmithKline Plc, Toray Industries, Inc. and Sphaera Pharma Pvt. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bifunctional Epoxide Hydrolase 2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bifunctional Epoxide Hydrolase 2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bifunctional Epoxide Hydrolase 2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bifunctional Epoxide Hydrolase 2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Bifunctional Epoxide Hydrolase 2 Segment by Company

Sumitomo Dainippon Pharma Co., Ltd.

GlaxoSmithKline Plc

Toray Industries, Inc.

Sphaera Pharma Pvt. Ltd.

Bifunctional Epoxide Hydrolase 2 Segment by Type

EC-5026

GSK-2256294

RB-394

Others

Bifunctional Epoxide Hydrolase 2 Segment by Application

Kidney Cancer

Liver Cancer

Lung Cancer

Others

Bifunctional Epoxide Hydrolase 2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bifunctional Epoxide Hydrolase 2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bifunctional Epoxide Hydrolase 2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bifunctional Epoxide Hydrolase 2 significant trends, drivers, influence factors in global and regions.

6. To analyze Bifunctional Epoxide Hydrolase 2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifunctional Epoxide Hydrolase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bifunctional Epoxide Hydrolase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifunctional Epoxide Hydrolase 2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bifunctional Epoxide Hydrolase 2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bifunctional Epoxide Hydrolase 2 industry.

Chapter 3: Detailed analysis of Bifunctional Epoxide Hydrolase 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bifunctional Epoxide Hydrolase 2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bifunctional Epoxide Hydrolase 2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bifunctional Epoxide Hydrolase 2 Industry Trends Table 2. Bifunctional Epoxide Hydrolase 2 Industry Drivers Table 3. Bifunctional Epoxide Hydrolase 2 Industry Opportunities and Challenges Table 4. Bifunctional Epoxide Hydrolase 2 Industry Restraints Table 5. Global Bifunctional Epoxide Hydrolase 2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bifunctional Epoxide Hydrolase 2 Revenue Share by Company (2021-2026) Table 7. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Company (2021-2026) Table 9. Global Bifunctional Epoxide Hydrolase 2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bifunctional Epoxide Hydrolase 2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bifunctional Epoxide Hydrolase 2 Key Company Manufacturing Base & Headquarters Table 12. Global Bifunctional Epoxide Hydrolase 2 Company, Product Type & Application Table 13. Global Bifunctional Epoxide Hydrolase 2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bifunctional Epoxide Hydrolase 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of EC-5026 Table 18. Significant Companies of GSK-2256294 Table 19. Significant Companies of RB-394 Table 20. Significant Companies of Others Table 21. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Type (2021-2026) Table 25. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Type (2027-2032) Table 26. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type (2021-2026) Table 30. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Kidney Cancer Table 32. Significant Companies of Liver Cancer Table 33. Significant Companies of Lung Cancer Table 34. Significant Companies of Others Table 35. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 36. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021-2026) & (W Units) Table 37. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2027-2032) & (W Units) Table 38. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Application (2021-2026) Table 39. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Application (2027-2032) Table 40. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application (2021-2026) Table 44. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application (2027-2032) Table 45. Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 46. Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2021-2026) & (W Units) Table 47. Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Region (2021-2026) Table 48. Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2027-2032) & (W Units) Table 49. Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Region (2027-2032) Table 50. Global Bifunctional Epoxide Hydrolase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Region (2021-2026) Table 53. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Region (2027-2032) Table 55. Global Bifunctional Epoxide Hydrolase 2 Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Bifunctional Epoxide Hydrolase 2 Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Bifunctional Epoxide Hydrolase 2 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2026) & (W Units) Table 60. Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Country (2021-2026) Table 61. Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2027-2032) & (W Units) Table 62. Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Country (2027-2032) Table 63. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Bifunctional Epoxide Hydrolase 2 Sales Value Market Share by Country (2021-2026) Table 65. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Bifunctional Epoxide Hydrolase 2 Sales Value Market Share by Country (2027-2032) Table 67. Sumitomo Dainippon Pharma Co., Ltd. Company Information Table 68. Sumitomo Dainippon Pharma Co., Ltd. Business Overview Table 69. Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio Table 71. Sumitomo Dainippon Pharma Co., Ltd. Recent Development Table 72. GlaxoSmithKline Plc Company Information Table 73. GlaxoSmithKline Plc Business Overview Table 74. GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Product Portfolio Table 76. GlaxoSmithKline Plc Recent Development Table 77. Toray Industries, Inc. Company Information Table 78. Toray Industries, Inc. Business Overview Table 79. Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Product Portfolio Table 81. Toray Industries, Inc. Recent Development Table 82. Sphaera Pharma Pvt. Ltd. Company Information Table 83. Sphaera Pharma Pvt. Ltd. Business Overview Table 84. Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio Table 86. Sphaera Pharma Pvt. Ltd. Recent Development Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Bifunctional Epoxide Hydrolase 2 Distributors List Table 90. Bifunctional Epoxide Hydrolase 2 Customers List Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Bifunctional Epoxide Hydrolase 2 Product Image Figure 2. Global Bifunctional Epoxide Hydrolase 2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bifunctional Epoxide Hydrolase 2 Sales (2021-2032) & (W Units) Figure 5. Global Bifunctional Epoxide Hydrolase 2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bifunctional Epoxide Hydrolase 2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. EC-5026 Image Figure 10. GSK-2256294 Image Figure 11. RB-394 Image Figure 12. Others Image Figure 13. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Type (2021-2032) Figure 16. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type (2021-2032) Figure 19. Kidney Cancer Image Figure 20. Liver Cancer Image Figure 21. Lung Cancer Image Figure 22. Others Image Figure 23. Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Application (2021-2032) Figure 26. Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application (2021-2032) Figure 29. Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 30. Global Bifunctional Epoxide Hydrolase 2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Bifunctional Epoxide Hydrolase 2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 34. North America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 40. South America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Bifunctional Epoxide Hydrolase 2 Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Bifunctional Epoxide Hydrolase 2 Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • EC-5026
  • GSK-2256294
  • RB-394
  • Others
Applications
  • Kidney Cancer
  • Liver Cancer
  • Lung Cancer
  • Others
Companies covered
  • Sumitomo Dainippon Pharma Co., Ltd.
  • GlaxoSmithKline Plc
  • Toray Industries, Inc.
  • Sphaera Pharma Pvt. Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  4. 1.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume (2021-2032)
  5. 1.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bifunctional Epoxide Hydrolase 2 Market Dynamics
  1. 2.1 Bifunctional Epoxide Hydrolase 2 Industry Trends
  2. 2.2 Bifunctional Epoxide Hydrolase 2 Industry Drivers
  3. 2.3 Bifunctional Epoxide Hydrolase 2 Industry Opportunities and Challenges
  4. 2.4 Bifunctional Epoxide Hydrolase 2 Industry Restraints
3 Bifunctional Epoxide Hydrolase 2 Market by Company
  1. 3.1 Global Bifunctional Epoxide Hydrolase 2 Company Revenue Ranking in 2025
  2. 3.2 Global Bifunctional Epoxide Hydrolase 2 Revenue by Company (2021-2026)
  3. 3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Bifunctional Epoxide Hydrolase 2 Average Price by Company (2021-2026)
  5. 3.5 Global Bifunctional Epoxide Hydrolase 2 Company Ranking (2024-2026)
  6. 3.6 Global Bifunctional Epoxide Hydrolase 2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Bifunctional Epoxide Hydrolase 2 Company Product Type and Application
  8. 3.8 Global Bifunctional Epoxide Hydrolase 2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bifunctional Epoxide Hydrolase 2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bifunctional Epoxide Hydrolase 2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bifunctional Epoxide Hydrolase 2 Market by Type
  1. 4.1 Bifunctional Epoxide Hydrolase 2 Type Introduction
  2. 4.1.1 EC-5026
  3. 4.1.2 GSK-2256294
  4. 4.1.3 RB-394
  5. 4.1.4 Others
  6. 4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type
  7. 4.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type
  11. 4.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Type (2021-2032)
  13. 4.3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type (2021-2032)
5 Bifunctional Epoxide Hydrolase 2 Market by Application
  1. 5.1 Bifunctional Epoxide Hydrolase 2 Application Introduction
  2. 5.1.1 Kidney Cancer
  3. 5.1.2 Liver Cancer
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application
  7. 5.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Bifunctional Epoxide Hydrolase 2 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application
  11. 5.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application (2021-2032)
6 Bifunctional Epoxide Hydrolase 2 Regional Sales and Value Analysis
  1. 6.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2021-2032)
  3. 6.2.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Region: 2021-2026
  4. 6.2.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Region (2027-2032)
  5. 6.3 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Region (2027-2032)
  9. 6.5 Global Bifunctional Epoxide Hydrolase 2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  12. 6.6.2 North America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  15. 6.7.2 Europe Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  21. 6.9.2 South America Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bifunctional Epoxide Hydrolase 2 Sales Value Share by Country, 2025 VS 2032
7 Bifunctional Epoxide Hydrolase 2 Country-level Sales and Value Analysis
  1. 7.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2032)
  4. 7.3.1 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2021-2026)
  5. 7.3.2 Global Bifunctional Epoxide Hydrolase 2 Sales by Country (2027-2032)
  6. 7.4 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bifunctional Epoxide Hydrolase 2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bifunctional Epoxide Hydrolase 2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sumitomo Dainippon Pharma Co., Ltd.
  2. 8.1.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
  3. 8.1.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  4. 8.1.3 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sumitomo Dainippon Pharma Co., Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
  6. 8.1.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
  7. 8.2 GlaxoSmithKline Plc
  8. 8.2.1 GlaxoSmithKline Plc Company Information
  9. 8.2.2 GlaxoSmithKline Plc Business Overview
  10. 8.2.3 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Plc Bifunctional Epoxide Hydrolase 2 Product Portfolio
  12. 8.2.5 GlaxoSmithKline Plc Recent Developments
  13. 8.3 Toray Industries, Inc.
  14. 8.3.1 Toray Industries, Inc. Company Information
  15. 8.3.2 Toray Industries, Inc. Business Overview
  16. 8.3.3 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Toray Industries, Inc. Bifunctional Epoxide Hydrolase 2 Product Portfolio
  18. 8.3.5 Toray Industries, Inc. Recent Developments
  19. 8.4 Sphaera Pharma Pvt. Ltd.
  20. 8.4.1 Sphaera Pharma Pvt. Ltd. Company Information
  21. 8.4.2 Sphaera Pharma Pvt. Ltd. Business Overview
  22. 8.4.3 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sphaera Pharma Pvt. Ltd. Bifunctional Epoxide Hydrolase 2 Product Portfolio
  24. 8.4.5 Sphaera Pharma Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bifunctional Epoxide Hydrolase 2 Value Chain Analysis
  2. 9.1.1 Bifunctional Epoxide Hydrolase 2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bifunctional Epoxide Hydrolase 2 Sales Mode & Process
  6. 9.2 Bifunctional Epoxide Hydrolase 2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bifunctional Epoxide Hydrolase 2 Distributors
  9. 9.2.3 Bifunctional Epoxide Hydrolase 2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research